New, more convenient form of leading schizophrenia medication Risperdal now available.

13 мая, 2003
A new, fast-dissolving form of the schizophrenia medication Risperdal will be launched during the second week of May 2003. Risperdal M-Tab dissolves in seconds when placed on the tongue. Chemical Business NewsBase - Press Release via NewsEdge Corporation : A new, fast-dissolving form of the schizophrenia medication Risperdal (risperidone) will be launched during the second week of May 2003. Risperdal M-Tab dissolves in seconds when placed on the tongue. Risperdal, marketed by Janssen Pharmaceutica Products LP, is the most widely prescribed antipsychotic medication in the US. Risperdal M-Tab tablets are produced using freeze-drying technology, creating highly porous tablets that rapidly disintegrate upon contact with saliva. The coral-coloured, peppermint-flavoured tablets will be available in 0.5 mg, 1 mg and 2 mg doses and are bioequivalent to comparable dosages of the original-formulation tablets. In clinical trials, Risperdal was generally well tolerated. Based in Titusville, NJ, Janssen Pharmaceutica Products LP, a wholly owned subsidiary of Johnson & Johnson, has a long track record in developing and marketing treatments for central nervous system disorders. Publication: Chemical Business NewsBase - Press Release Distributed by Financial Times Information Limited - Asia Africa Intelligence Wire <> << Copyright ©2003 Financial Times Limited, All Rights Reserved >>
Разделы
Новости